Ashworth L A, Robinson A, Irons L I, Morgan C P, Isaacs D
Lancet. 1983 Oct 15;2(8355):878-81. doi: 10.1016/s0140-6736(83)90869-3.
The content of 3 antigens--filamentous haemagglutinin, lymphocytosis-promoting factor, and serotype-specific agglutinogens (fimbriae)--was determined in the current UK whole-cell whooping cough vaccine. Antibodies to these antigens and to outer membrane proteins and lipopolysaccharide of Bordetella pertussis were measured in the serum of unvaccinated children and children who had received 1, 2, or 3 doses of the vaccine. Children who had received one dose of vaccine had varied low antibody titres. Children who had received two or three doses had significantly higher antibody titres to all the antigens tested, as did some unvaccinated children with no history of whooping cough. This study shows that filamentous haemagglutinin, lymphocytosis promoting factor, and outer membrane proteins are immunogenic constituents of the whole-cell vaccine. Their inclusion in a subcellular vaccine would not involve novel antigens.
在当前英国全细胞百日咳疫苗中测定了3种抗原的含量,即丝状血凝素、淋巴细胞增多促进因子和血清型特异性凝集原(菌毛)。在未接种疫苗的儿童以及接种了1剂、2剂或3剂该疫苗的儿童血清中,检测了针对这些抗原以及百日咳博德特氏菌外膜蛋白和脂多糖的抗体。接种了1剂疫苗的儿童抗体滴度较低且各不相同。接种了2剂或3剂疫苗的儿童,以及一些无百日咳病史的未接种疫苗儿童,针对所有检测抗原的抗体滴度均显著更高。本研究表明,丝状血凝素、淋巴细胞增多促进因子和外膜蛋白是全细胞疫苗的免疫原性成分。将它们纳入亚细胞疫苗不会涉及新的抗原。